➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Medtronic
Merck
Mallinckrodt
AstraZeneca

Last Updated: June 15, 2021

DrugPatentWatch Database Preview

EXTAVIA Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for Tradename: EXTAVIA
Patents:40
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for EXTAVIA
Recent Clinical Trials for EXTAVIA

Identify potential brand extensions & biosimilar entrants

SponsorPhase
BiogenPhase 4
NeuroCure Clinical Research CenterPhase 2/Phase 3
Charite University, Berlin, GermanyPhase 2/Phase 3

See all EXTAVIA clinical trials

Patent Text Search: US Patents for EXTAVIA

These patents were identified by searching patent claims

Supplementary Protection Certificates for EXTAVIA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2016/052 Ireland   Get Started Free PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160701
313 5027-2016 Slovakia   Get Started Free PRODUCT NAME: DAKLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160705
C 2016 046 Romania   Get Started Free PRODUCT NAME: DACLIZUMAB; NATIONAL AUTHORISATION NUMBER: EU/1/16/1107; DATE OF NATIONAL AUTHORISATION: 20160701; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/16/1107; DATE OF FIRST AUTHORISATION IN EEA: 20160701
C20160039 00209 Estonia   Get Started Free PRODUCT NAME: DAKLIZUMAB;REG NO/DATE: EU/1/16/1107 05.07.2016
132016000123360 Italy   Get Started Free PRODUCT NAME: DACLIZUMAB(ZINBRYTA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/16/1107, 20160705
1690055-7 Sweden   Get Started Free PRODUCT NAME: DACLIZUMAB OR A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR SOLVATE THEREOF; REG. NO/DATE: EU/1/16/1107 20160705
122016000098 Germany   Get Started Free PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160701
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
McKinsey
Dow
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.